Law Offices of Brian M. Felgoise, P.C. Announces Class Action Lawsuit on Behalf of Shareholders of Omrix Biopharmaceuticals, Inc
03 Dezember 2008 - 7:45PM
Marketwired
Law Offices of Brian M. Felgoise, P.C. announces that a class
action has been commenced on behalf of shareholders of Omrix
Biopharmaceuticals, Inc. (NASDAQ: OMRI) in connection with the
offer by Johnson & Johnson to acquire all of the outstanding
shares of OMRI.
The case is pending in The Supreme Court of the State of New
York, County of New York against certain officers and directors.
The goal of the lawsuit is to seek the highest possible offer for
the public shares.
If you are a holder of Omrix Biopharmaceuticals, Inc. stock and
want to discuss your legal rights, you may e-mail or call Law
Offices of Brian M. Felgoise, P.C. who will, without obligation or
cost to you, attempt to answer your questions. Law Offices of Brian
M. Felgoise, P.C. has extensive experience in the field of class
actions. You may contact Brian M. Felgoise, Esquire at 261 Old York
Road, Suite 423, Jenkintown, Pennsylvania 19046, by calling (215)
886-1900 or by e-mail at FelgoiseLaw@verizon.net.
Please Contact: Law Offices of Brian M. Felgoise, P.C. 261 Old
York Road, Suite 423 Jenkintown, PA 19046 Email Contact
Omrix Biopharmaceuticals (MM) (NASDAQ:OMRI)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Omrix Biopharmaceuticals (MM) (NASDAQ:OMRI)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Omrix Biopharmaceuticals (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Law Offices of Brian M. Felgoise, P.C. News-Artikel